| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 2 | -2,352,664 | 100% | $4.16 | -$9,783,789 |
| Net | -2 | -2,352,664 | -100% | -$9,783,789 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Peter A. Thompson | Director, 10%+ Owner | $66,735,200 | -$4,891,894 | -6.8% | 28 Jan 2026 |
| ORBIMED ADVISORS LLC | Director, 10%+ Owner | $29,796,393 | -$4,891,894 | -14% | 27 Jun 2025 |
| Richard A. Miller | President and CEO, Director | $7,435,853 | 04 Dec 2025 | ||
| Terry P. Gould | Director, 10%+ Owner | $5,670,746 | 13 Jun 2024 | ||
| ADAMS STREET PARTNERS LLC | 10%+ Owner | $2,587,737 | 11 Aug 2022 | ||
| William Benton Jones | SVP, Pharmaceutical Development | $605,955 | 04 Dec 2025 | ||
| EcoR1 Capital, LLC | 10%+ Owner | $64,051 | 30 Sep 2021 | ||
| Leiv Lea | Chief Financial Officer | 04 Dec 2025 | |||
| IAN T. CLARK | Director | 12 Jun 2025 | |||
| Richard van den Broek | Director | 08 Apr 2025 | |||
| Edith P. Mitchell | Director | 06 Dec 2023 | |||
| David Scott Moore | Director | 02 Oct 2025 | |||
| Linda Grais | Director | 12 Jun 2025 | |||
| Jeffrey Arcara | Chief Business Officer | 04 Dec 2025 | |||
| Scott W. Morrison | Director | 12 Jun 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|